Samuel Bourdon, Co-Founder and Chief Executive Officer of Statera Medical discusses Statera Medical’s development of a smart shoulder implant.

In an interview withSmartTRAK,Samuel Bourdon, the Co-Founder and Chief Executive Officer of Statera Medical, discusses how Statera Medical came to be, why their focused on creating a smart implant for the shoulder arthroplasty market and where he sees the Company going in the future.

To find out more, including the design rationale behind Statera’s smart shoulder ecosystem and how Statera fits in the shoulder arthroplasty market, click on the following video to listen to the full interview (29:25). If you would like to download the complete transcript of the interview, click here.

SmartTRAK: Hey guys, this is Nick with SmartTRAK. I'm here with Samuel Bourdon, CEO and founder of Statera Medical. I appreciate you joining me this morning and doing this interview. Samuel, can you give us an introduction about your yourself and a brief background of your experience in the orthopedics industry?

Samuel Bourdon: I'm a mechanical engineer by training. I have worked in product development since 2012 and mostly in the aerospace and recreational product. And when I turned 30, I quit my job and decided to go back to school to do a full-time master degree in biomedical engineering. And then I managed to do a master in business administration part-time during the same period. So before Statera Medical I had no experience in orthopedic industry at all, so it's a first time for me.

That's definitely monumental. Why'd you switch from aerospace to biomedical?

SB: Yeah, I just hit a bigger why in my career and I wanted to put a human at the center of it, so that's what made me took that decision.

Where did you get your master's in biomed from?

SB: From Polytechnique Montreal. It's the same university I got my mechanical engineer degree.

Let's dive into the company that you founded, Statera Medical. So what was the inspiration behind founding Statera Medical, and what's your mission statement behind it?

SB: What happened is I met another engineer and an orthopedic surgeon, and it was really all about reducing complication rates and improving patient outcomes, which ultimately results in ...

To download the complete transcript of SmartTRAK's interview with Samuel Bourdon, the Co-Founder and CEO of Statera Medical, just click the button below.

Strong returns in IM Nailing and a flurry of activity in the Pediatric space results in a healthy Q123 for the Trauma Market

Orahn Preiss-Bloom, founder and Chief Innovation Officer of Ossio Ltd. discusses Osssio’s advancements in innovations in the world of bio-integrative fixation devices.

In an interview with SmartTRAK, Orahn Preiss-Bloom, the founder and Chief Innovation Officer of Ossio Ltd, discusses how Ossio came to be, what makes their products different and where he sees the Company going in the future.

To find out more about Ossio, click on the following video to watch the interview (24:42 min). To download a complete transcript of the interview, click here. For more details, interview topics by timecode are provided below.

Interview Topics By Timecode

00:44 Orahn’s background in the medical industry.
03:53 What differentiates the OSSIO product.
07:55 Initial uses for OSSIOfiber.
12:40 Overcoming surgeon objections to biointegrative materials.
15:13 Ossio education labs.
19:44 Ossio in sports medicine.
22:41 Surgeon concerns.

To download the complete transcript of the interview with Orahn Preiss-Bloom, Founder and Chief Innovation Officer of Ossio Ltd, just click the button below.

SmartTRAK highlights trends affecting the US Extremities Market in 2023

Among the many topics covered in detail in this comprehensive article are:

• SmartTRAK's Expert Market Analysis and Insights
• Outpatient Shoulder Replacement Growing Despite Lack of CMS Reimbursement
• New Shoulders May Heat Up Competition
• New Ankle Products and Technologies May Boost Growth
• New Products, DTC and Potential M&As Heat Up Extremities Fixation
• M&As on the Horizon

To download and read the complete "2023 Extremities Trends to Watch" article, just click the button below.

The countdown to AAOS 2023 on March 7-11 in Las Vegas has begun and the SmartTRAK team will be attending...see you there!

SmartTRAK highlights new products and Company strategies to penetrate the Foot & Ankle space at AOFAS 2022

SmartTRAK identified several key themes and takeaways from the American Orthopaedic Foot & Ankle Society (AOFAS) 2022 meeting held recently in Quebec City, Canada. Manufacturers showcased product introductions with a continued focus on hallux valgus solutions and are investing in solutions beyond implants to differentiate themselves and gain share in the US Foot & Ankle Market.

Among the many topics covered in detail in the complete article, which can be downloaded here, are:

• Small, Niche Players Attempt to Gain Share
  • Globus Fills Out Trauma and Extremities Product Portfolios
  • Enovis Showcases New Products and Gains Traction in F&A Space
• Direct-To-Consumer Marketing Drives Growth in Hallux Valgus Market
  • Treace Medical Outpaces Others
  • Medartis Showcases New Products
  • JNJ/DePuy/Synthes' Acquisition
  • Paragon28 Focuses on the MIS Segment

To download the complete "AOFAS 2022: Trends and Advancements in Foot & Ankle" article by SmartTRAK's Natasha Weeks, Sr. Analyst, Trauma & Extremities, just click the button below.

SmartTRAK highlights the latest trends and innovations at OTA 2022, with a focus on deformity correction and limb lengthening.

Stepping Outside of Internal Fixation

In the market for ring fixation devices, companies have been innovating beyond static frames and are developing dynamic, computer-assisted hexapod frames to treat bone fractures and deformity corrections. One of the challenges with hexapod frames is that they require manual strut adjustments, a process that is prone to patient and clinician error and can require up to 20 manual adjustments per day—a definite burden on the patient and caregiver ...